572 related articles for article (PubMed ID: 27488002)
21. Genetic association of interleukin-1beta (-511C/T) and interleukin-1 receptor antagonist (86 bp repeat) polymorphisms with Type 2 diabetes mellitus in North Indians.
Achyut BR; Srivastava A; Bhattacharya S; Mittal B
Clin Chim Acta; 2007 Feb; 377(1-2):163-9. PubMed ID: 17069782
[TBL] [Abstract][Full Text] [Related]
22. Cytokine gene polymorphisms in Colombian patients with systemic lupus erythematosus.
Guarnizo-Zuccardi P; Lopez Y; Giraldo M; Garcia N; Rodriguez L; Ramirez L; Uribe O; Garcia L; Vasquez G
Tissue Antigens; 2007 Nov; 70(5):376-82. PubMed ID: 17711410
[TBL] [Abstract][Full Text] [Related]
23. Interleukin 10 gene promoter polymorphisms (rs1800896, rs1800871 and rs1800872) and haplotypes are associated with the activity of systemic lupus erythematosus and IL10 levels in an Iranian population.
Mohammadi S; Saghaeian Jazi M; Zare Ebrahimabad M; Eghbalpour F; Abdolahi N; Tabarraei A; Yazdani Y
Int J Immunogenet; 2019 Feb; 46(1):20-30. PubMed ID: 30430731
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-1beta -511T>C genetic variant contributes to recurrent pregnancy loss risk and peripheral natural killer cell proportion.
Kim JO; Lee WS; Lee BE; Jeon YJ; Kim YR; Jung SH; Chang SW; Kim NK
Fertil Steril; 2014 Jul; 102(1):206-212.e5. PubMed ID: 24784935
[TBL] [Abstract][Full Text] [Related]
25. Impact of the IL-17F, IL-23 and IL-23R on susceptibility and phenotype of systemic lupus erythematosus.
Paradowska-Gorycka A; Sowinska A; Stypinska B; Grobelna MK; Walczyk M; Olesinska M; Piotrowski P; Jagodziński PP
Autoimmunity; 2016 Sep; 49(6):373-382. PubMed ID: 27320770
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-1β and interleukin-1receptor antagonist polymorphisms in Egyptian children with febrile seizures: A case-control study.
Al Morshedy S; Elsaadany HF; Ibrahim HE; Sherif AM; Farghaly MAA; Allah MAN; Abouzeid H; Elashkar SSA; Hamed ME; Fathy MM; Khalil AM; Noah MA; Hegab MS; Ahmed AR; Hashem MIA; Emam AA; Anany HG; Ibrahim BR; Gawish HH; Nabil RM; Fattah LA; Alsayed SF
Medicine (Baltimore); 2017 Mar; 96(11):e6370. PubMed ID: 28296777
[TBL] [Abstract][Full Text] [Related]
27. Genetic polymorphisms of IL-27 and risk of systemic lupus erythematosus disease in the Egyptian population.
Ali YBM; El-Akhras BA; El-Shazly R; Bassyouni IH
Clin Rheumatol; 2021 Dec; 40(12):4899-4907. PubMed ID: 34324143
[TBL] [Abstract][Full Text] [Related]
28. IL-1β+3953C/T, -511T/C and IL-6 -174C/G polymorphisms in association with tuberculosis susceptibility: A meta-analysis.
Mao X; Ke Z; Liu S; Tang B; Wang J; Huang H; Chen S
Gene; 2015 Nov; 573(1):75-83. PubMed ID: 26169021
[TBL] [Abstract][Full Text] [Related]
29. [Correlation between -31 T/C polymorphisms of
interleukin-1β gene and Kawasaki disease].
Zou D; Ahmed Mohamed E; Jiang J; Tian L; Chen J; Li Z; Yang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Jan; 42(1):8-12. PubMed ID: 28216491
[TBL] [Abstract][Full Text] [Related]
30. Impact of eNOS 27-bp VNTR (4b/a) gene polymorphism with the risk of Systemic Lupus Erythematosus in south Indian subjects.
Katkam SK; Indumathi B; Tasneem FSD; Rajasekhar L; Kutala VK
Gene; 2018 Jun; 658():105-112. PubMed ID: 29524578
[TBL] [Abstract][Full Text] [Related]
31. Association of interleukin 13 gene polymorphisms and plasma IL 13 level with risk of systemic lupus erythematosus.
Wang R; Lu YL; Huang HT; Qin HM; Lan Y; Wang JL; Wang CF; Wei YS
Cytokine; 2018 Apr; 104():92-97. PubMed ID: 29017771
[TBL] [Abstract][Full Text] [Related]
32. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1--receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene.
Langdahl BL; Løkke E; Carstens M; Stenkjaer LL; Eriksen EF
J Bone Miner Res; 2000 Mar; 15(3):402-14. PubMed ID: 10750554
[TBL] [Abstract][Full Text] [Related]
33. Association of interleukin-10 gene single nucleotide polymorphisms with susceptibility to systemic lupus erythematosus in a Chinese population.
Lv TT; Wu J; Li J; Zhang TP; Yang XK; Xiang N; Fan YG; Pan HF; Wang B
Gene; 2018 Feb; 642():549-554. PubMed ID: 29199038
[TBL] [Abstract][Full Text] [Related]
34. Toll-like receptor 4 gene polymorphism 1196 C/T does not influence the risk of neuropsychiatric systemic lupus erythematosus in Polish population--a preliminary report.
Bogaczewicz A; Sobow T; Bogaczewicz J; Kaleta B; Sysa-Jedrzejowska A; Robak E; Lukaszkiewicz J; Dariusz S; Wozniacka A
Lupus; 2013 Dec; 22(14):1504-8. PubMed ID: 24243911
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-1β, Interleukin1-Ra, Interleukin-10, and tumor necrosis factor-α polymorphisms in Tunisian patients with rheumatoid arthritis.
Lagha A; Zidi S; Stayoussef M; Gazouani E; Kochkar R; Kochbati S; Almawi WY; Yacoubi-Loueslati B
Pathol Biol (Paris); 2015 Sep; 63(4-5):179-84. PubMed ID: 26003199
[TBL] [Abstract][Full Text] [Related]
36. CD14 (C-159T) polymorphism is associated with increased susceptibility to SLE, and plasma levels of soluble CD14 is a novel biomarker of disease activity: A hospital-based case-control study.
Panda AK; Tripathy R; Das BK
Lupus; 2021 Feb; 30(2):219-227. PubMed ID: 33176568
[TBL] [Abstract][Full Text] [Related]
37. The association between Interleukin (IL)-4 gene intron 3 VNTR polymorphism and alopecia areata (AA) in Turkish population.
Kalkan G; Karakus N; Baş Y; Takçı Z; Ozuğuz P; Ateş O; Yigit S
Gene; 2013 Sep; 527(2):565-9. PubMed ID: 23831512
[TBL] [Abstract][Full Text] [Related]
38. Distribution of PTPN22 polymorphisms in SLE from western Mexico: correlation with mRNA expression and disease activity.
Machado-Contreras JR; Muñoz-Valle JF; Cruz A; Salazar-Camarena DC; Marín-Rosales M; Palafox-Sánchez CA
Clin Exp Med; 2016 Aug; 16(3):399-406. PubMed ID: 26013387
[TBL] [Abstract][Full Text] [Related]
39. The association of CD40 polymorphism (rs1883832C/T) and soluble CD40 with the risk of systemic lupus erythematosus among Egyptian patients.
Mousa TG; Omar HH; Emad R; Salama MI; Omar W; Fawzy M; Hassoba HM
Clin Rheumatol; 2019 Mar; 38(3):777-784. PubMed ID: 30374748
[TBL] [Abstract][Full Text] [Related]
40. Interleukin 1-beta responses to bacterial toxins and sudden infant death syndrome.
Moscovis SM; Gordon AE; Hall ST; Gleeson M; Scott RJ; Roberts-Thomsom J; Weir DM; Busuttil A; Blackwell CC
FEMS Immunol Med Microbiol; 2004 Sep; 42(1):139-45. PubMed ID: 15325407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
